RCR | algorithm

Login

Forget your password
Creat New account

Home
Excellence in Dyslipidemia
RCR
Newsletters
Events
Contact us
Registration
Login

Residual Cardiovascular Risk

ADDRESSING RESIDUAL RISK IN 2020
LDL-C DRIVEN RR
TRIGLYCERIDE-RICH LIPOPROTEIN RR
DIABETES-DRIVEN RR
HYPERTENSION RR
CHRONIC KIDNEY DISEASE, VASCULAR DISEASE AND RR
LIPOPROTEIN(A)-DRIVEN RR
ASSESSMENT 1
INFLAMMATION-driven RR
ATHERO-THROMBOTIC RR
LABORATORY BIOMARKERS TO ADDRESS RR
CVD BURDEN OF ILLNESS IN THE GULF REGION AND UNMET MEDICAL NEEDS
HOW THE NEW GUIDELINES ARE APPROACHING THE RR
COST EFFECTIVE PATIENT MANAGEMENT TO REDUCE MORTALITY
ASSESSMENT 2

About Us

Algorithm is a regional Pharmaceutical Company operating in the MENA region and committed to improving human health and well-being. As partners to the medical societies and since our aim is to provide patients with updated healthcare practices, we developed this Continuous Medical Education (CME) program to be the core of our dedication towards an enhanced patient care.

Get In Touch

info@dyslipidemiame.com

All Rights reserved to dyslipidemiame.com
Powered by Eureka digital 2022